{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:13:34Z","timestamp":1784074414530,"version":"3.55.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.trre.2024.100885","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T17:11:12Z","timestamp":1730999472000},"page":"100885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complement and complement regulatory protein in allogeneic and xenogeneic kidney transplantation"],"prefix":"10.1016","volume":"39","author":[{"given":"Yoichi","family":"Kakuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Higa-Maegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Fukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Nonomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2024.100885_bb0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2023.0526","article-title":"The organ shortage continues to be a crisis for patients with end-stage kidney disease","volume":"158","author":"Matas","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.trre.2024.100885_bb0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/ckj\/sfab273","article-title":"The ERA registry annual report 2019: summary and age comparisons","volume":"15","author":"Boenink","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.trre.2024.100885_bb0015","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100885_bb0020","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/j.ajkd.2013.03.022","article-title":"Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review","volume":"62","author":"Purnell","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2024.100885_bb0025","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra0902927","article-title":"Rejection of the kidney allograft","volume":"363","author":"Nankivell","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100885_bb0030","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100885_bb0035","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrneph.2012.212","article-title":"The role of complement in antibody-mediated rejection in kidney transplantation","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2024.100885_bb0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nm0602-582","article-title":"Local synthesis of complement component C3 regulates acute renal transplant rejection","volume":"8","author":"Pratt","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2024.100885_bb0050","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1681\/ASN.0000000000000192","article-title":"Targeting the complement pathway in kidney transplantation","volume":"34","author":"Golshayan","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100885_bb0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00007890-198812000-00007","article-title":"The mechanism of discordant xenograft rejection","volume":"46","author":"Miyagawa","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0060","first-page":"68","article-title":"Complement and human T cell metabolism: location, location, location","volume":"295","author":"West","year":"2020","journal-title":"Immunol Res"},{"key":"10.1016\/j.trre.2024.100885_bb0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.trre.2024.100885_bb0075","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100885_bb0080","doi-asserted-by":"crossref","first-page":"I3","DOI":"10.1016\/j.vaccine.2008.11.010","article-title":"Inherited complement deficiencies and bacterial infections","volume":"26","author":"Tedesco","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.trre.2024.100885_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI115314","article-title":"Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells","volume":"88","author":"Brooimans","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trre.2024.100885_bb0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.ackd.2019.10.003","article-title":"Complement and the kidney: an overview","volume":"27","author":"Thurman","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.trre.2024.100885_bb0095","doi-asserted-by":"crossref","first-page":"16969","DOI":"10.1073\/pnas.012669199","article-title":"The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice","volume":"99","author":"Brown","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trre.2024.100885_bb0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4049\/jimmunol.179.1.455","article-title":"Localization and characterization of the mannose-binding lectin (MBL)-associated-serine protease-2 binding site in rat ficolin-a: equivalent binding sites within the collagenous domains of MBLs and ficolins","volume":"179","author":"Girija","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2010.173","article-title":"Dynamic control of the complement system by modulated expression of regulatory proteins","volume":"91","author":"Thurman","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.trre.2024.100885_bb0110","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.20040863","article-title":"The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo","volume":"201","author":"Liu","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.trre.2024.100885_bb0120","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.4049\/jimmunol.175.9.6219","article-title":"Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor\/CD55 in dysferlin-deficient muscular dystrophy","volume":"175","author":"Wenzel","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0125","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.4049\/jimmunol.177.2.1070","article-title":"Costimulation via CD55 on human CD4+ T cells mediated by CD97","volume":"177","author":"Capasso","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0130","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.156.11.4415","article-title":"Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement","volume":"156","author":"Liszewski","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-015-0029-z","article-title":"Complement regulator CD46: genetic variants and disease associations","volume":"9","author":"Liszewski","year":"2015","journal-title":"Hum Genom"},{"key":"10.1016\/j.trre.2024.100885_bb0140","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.168.12.6298","article-title":"Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells","volume":"168","author":"Barilla-LaBarca","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0465","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.molimm.2010.05.007","article-title":"Complement control protein factor H: the good, the bad, and the inadequate","volume":"47","author":"Ferreira","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0470","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.1300638","article-title":"Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion","volume":"191","author":"Amdahl","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0475","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.kint.2022.07.035","article-title":"Factor H related proteins modulate complement activation on kidney cells","volume":"102","author":"Renner","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2024.100885_bb0480","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.148.1.207","article-title":"Human C4-binding protein. I. Isolation and characterization","volume":"148","author":"Scharfstein","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.trre.2024.100885_bb0485","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4049\/jimmunol.2300333","article-title":"Diverse functions of C4b-binding protein in health and disease","volume":"211","author":"Werner","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0250","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.semnephrol.2013.08.007","article-title":"Complement regulation of T-cell alloimmunity","volume":"33","author":"Cravedi","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.trre.2024.100885_bb0275","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3389\/fimmu.2019.00789","article-title":"Absence of Neu5Gc and presence of anti-Neu5Gc antibodies in humans-an evolutionary perspective","volume":"10","author":"Altman","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0375","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/325545a0","article-title":"Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins","volume":"325","author":"Caras","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.trre.2024.100885_bb0380","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4049\/jimmunol.129.1.184","article-title":"Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system","volume":"129","author":"Nicholson-Weller","year":"1982","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0385","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.4049\/jimmunol.167.4.2164","article-title":"Characterization of the active sites in decay-accelerating factor","volume":"167","author":"Kuttner-Kondo","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0390","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gut.2003.026773","article-title":"CD55 expression patterns on intestinal neuronal tissue are divergent from the brain","volume":"53","author":"Gelderman","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.trre.2024.100885_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860165","article-title":"Aspects of the complement system in new era of xenotransplantation","volume":"13","author":"Miyagawa","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0400","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.4049\/jimmunol.173.6.3945","article-title":"Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis","volume":"173","author":"Miyagawa","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0405","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M004650200","article-title":"Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46)","volume":"275","author":"Liszewski","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trre.2024.100885_bb0145","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2024.100885_bb0410","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1038\/s41467-018-06706-z","article-title":"Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism","volume":"9","author":"Arbore","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.trre.2024.100885_bb0415","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.144.9.3478","article-title":"The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9","volume":"144","author":"Rollins","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0420","first-page":"15","article-title":"Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts","volume":"70","author":"Cozzi","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0490","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/cmi.2008.17","article-title":"Activity after site-directed mutagenesis of CD59 on complement-mediated cytolysis","volume":"5","author":"Zhu","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0495","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-7-15","article-title":"Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice","volume":"7","author":"Harhausen","year":"2010","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.trre.2024.100885_bb0500","first-page":"24","article-title":"The ins and outs of clusterin: its role in cancer, eye diseases and wound healing","author":"Gross","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trre.2024.100885_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107451","article-title":"Mechanistic insights into complement pathway inhibition by CR1 domain duplication","volume":"300","author":"Wymann","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trre.2024.100885_bb0515","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2014.06.010","article-title":"How antibodies use complement to regulate antibody responses","volume":"61","author":"S\u00f6rman","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148881","article-title":"Depression of complement regulatory factors in rat and human renal grafts is associated with the progress of acute T-cell mediated rejection","volume":"11","author":"Yamanaka","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2024.100885_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101338","article-title":"The C1q receptors: focus on gC1qR\/p33 (C1qBP, p32, HABP-1)","volume":"45","author":"Ghebrehiwet","year":"2019","journal-title":"Semin Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrneph.2013.18","article-title":"Donor-specific HLA antibodies and renal allograft failure","volume":"9","author":"Loupy","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2024.100885_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.21037\/tau.2019.03.05","article-title":"Current protocols and outcomes of ABO-incompatible kidney transplantation based on a single-center experience","volume":"8","author":"Okumi","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.trre.2024.100885_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13591","article-title":"Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: a single-center Japanese cohort study","volume":"33","author":"Kakuta","year":"2019","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2024.100885_bb0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100885_bb0170","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100885_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000753","article-title":"Successful desensitization of T cell flow cytometry crossmatch positive renal transplant recipients using plasmapheresis and super high-dose intravenous immunoglobulin","volume":"4","author":"Kakuta","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2024.100885_bb0180","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100885_bb0185","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100885_bb0190","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/ajt.15175","article-title":"Long-term outcomes of eculizumab-treated positive crossmatch recipients: allograft survival, histologic findings, and natural history of the donor-specific antibodies","volume":"19","author":"Schinstock","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100885_bb0195","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1111\/ajt.15364","article-title":"Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: a randomized trial","volume":"19","author":"Marks","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100885_bb0200","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100885_bb0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100885_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2019.101230","article-title":"Prognostic value of C3d-fixing, preformed donor-specific antibodies in crossmatch-positive living kidney transplantation","volume":"57","author":"Miyake","year":"2019","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0215","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/TP.0000000000002002","article-title":"Prognostic value of the persistence of C1q-binding anti-HLA antibodies in acute antibody-mediated rejection in kidney transplantation","volume":"102","author":"Bailly","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/TP.0000000000000592","article-title":"A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0225","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1111\/ajt.13871","article-title":"Plasma-derived C1 esterase inhibitor for acute antibody-mediated rejection following kidney transplantation: results of a randomized double-blind placebo-controlled pilot study","volume":"16","author":"Montgomery","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100885_bb0230","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1038\/s41467-021-25745-7","article-title":"C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates","volume":"12","author":"Schmitz","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.trre.2024.100885_bb0235","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1038\/s41598-021-94954-3","article-title":"Multiplex gene analysis reveals T-cell and antibody-mediated rejection-specific upregulation of complement in renal transplants","volume":"11","author":"Vonbrunn","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.trre.2024.100885_bb0240","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/eji.1830250434","article-title":"Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts","volume":"25","author":"Andrews","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0245","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.4049\/jimmunol.179.9.5793","article-title":"Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production","volume":"179","author":"Lalli","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0255","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.88.16.7401","article-title":"Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys","volume":"88","author":"Galili","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trre.2024.100885_bb0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7555\/JBR.32.20180018","article-title":"Antigenicity of tissues and organs from GGTA1\/CMAH\/\u03b24GalNT2 triple gene knockout pigs","volume":"33","author":"Wang","year":"2018","journal-title":"J Biomed Res"},{"key":"10.1016\/j.trre.2024.100885_bb0265","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1073\/pnas.84.5.1369","article-title":"Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1-3Gal epitope in primates","volume":"84","author":"Galili","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trre.2024.100885_bb0270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nm1172","article-title":"Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue","volume":"11","author":"Yamada","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2024.100885_bb0280","doi-asserted-by":"crossref","first-page":"e12394","DOI":"10.1111\/xen.12394","article-title":"B4GALNT2 and xenotransplantation: a newly appreciated xenogeneic antigen","volume":"25","author":"Byrne","year":"2018","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0285","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1432-2277.2008.00736.x","article-title":"In vitro investigation of pig cells for resistance to human antibody-mediated rejection","volume":"21","author":"Hara","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100885_bb0290","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1432-2277.1994.tb01241.x","article-title":"Immunohistological studies of complement activation after xenogeneic perfusion of a working heart model","volume":"7","author":"Suckf\u00fcll","year":"1994","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100885_bb0295","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4049\/immunohorizons.2300056","article-title":"Patients on the transplant waiting list have anti-swine leukocyte antigen class I antibodies","volume":"7","author":"Wang","year":"2023","journal-title":"Immunohorizons"},{"key":"10.1016\/j.trre.2024.100885_bb0300","doi-asserted-by":"crossref","first-page":"e12560","DOI":"10.1111\/xen.12560","article-title":"Viable pigs after simultaneous inactivation of porcine MHC class I and three xenoreactive antigen genes GGTA1, CMAH and B4GALNT2","volume":"27","author":"Fischer","year":"2020","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0305","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0310","doi-asserted-by":"crossref","first-page":"e12862","DOI":"10.1111\/xen.12862","article-title":"Late graft failure of pig-to-rhesus renal xenografts has features of glomerulopathy and recipients have anti-swine leukocyte antigen class I and class II antibodies","volume":"31","author":"Ladowski","year":"2024","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103562","article-title":"\u201cyou cannot stay in the laboratory forever\u201d: taking pig kidney xenotransplantation from the laboratory to the clinic","volume":"71","author":"Cooper","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.trre.2024.100885_bb0320","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1399-3089.2005.00222.x","article-title":"Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells","volume":"12","author":"Ide","year":"2005","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0325","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1073\/pnas.0609661104","article-title":"Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages","volume":"104","author":"Ide","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trre.2024.100885_bb0330","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.trim.2013.08.001","article-title":"The suppression of inflammatory macrophage-mediated cytotoxicity and proinflammatory cytokine production by transgenic expression of HLA-E","volume":"29","author":"Maeda","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00595-017-1546-2","article-title":"Human CD200 suppresses macrophage-mediated xenogeneic cytotoxicity and phagocytosis","volume":"48","author":"Okuyama","year":"2018","journal-title":"Surg Today"},{"key":"10.1016\/j.trre.2024.100885_bb0340","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001175","article-title":"The regulation of neutrophil extracellular trap-induced tissue damage by human CD177","volume":"7","author":"Yoneyama","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2024.100885_bb0345","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.imbio.2019.07.008","article-title":"Human TIGIT on porcine aortic endothelial cells suppresses xenogeneic macrophage-mediated cytotoxicity","volume":"224","author":"Noguchi","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.trre.2024.100885_bb0350","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/TP.0000000000003024","article-title":"A strategy for suppressing macrophage-mediated rejection in xenotransplantation","volume":"104","author":"Maeda","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101663","article-title":"Suppression of macrophage-mediated xenogeneic rejection by the ectopic expression of human CD177","volume":"74","author":"Kogata","year":"2022","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2024.102020","article-title":"The hybrid CL-SP-D molecule has the potential to regulate xenogeneic rejection by human neutrophils more efficiently than CD47","volume":"84","author":"Iemitsu","year":"2024","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2024.100885_bb0365","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12396","article-title":"Human CD31 on porcine cells suppress xenogeneic neutrophil-mediated cytotoxicity via the inhibition of NETosis","volume":"25","author":"Wang","year":"2018","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0370","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1056\/NEJMoa1615887","article-title":"CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis","volume":"377","author":"Ozen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100885_bb0425","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/ajt.15329","article-title":"Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion","volume":"19","author":"Kim","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100885_bb0430","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0041-1345(00)02223-5","article-title":"The effect of anti-\u03b1Gal antibody removal with immunoabsorption and splenectomy on CD46 transgenic kidney xenograft survival","volume":"33","author":"Dean","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100885_bb0435","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1399-3089.2003.00103_11_2.x","article-title":"Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons","volume":"11","author":"Loveland","year":"2004","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0440","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation","volume":"622","author":"Anand","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.trre.2024.100885_bb0445","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/TP.0b013e3181a19afc","article-title":"Upregulation of CD59: potential mechanism of accommodation in a large animal model","volume":"87","author":"Griesemer","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100885_bb0450","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2201422","article-title":"Genetically modified porcine-to-human cardiac xenotransplantation","volume":"387","author":"Griffith","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2024.100885_bb0455","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.16930","article-title":"First clinical-grade porcine kidney xenotransplant using a human decedent model","volume":"22","author":"Porrett","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100885_bb0460","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175996","article-title":"C5 inhibition with eculizumab prevents thrombotic microangiopathy in a case series of pig-to-human kidney xenotransplantation","volume":"134","author":"Jones-Carr","year":"2024","journal-title":"J Clin Invest"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X24000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X24000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:12:55Z","timestamp":1736226775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X24000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0955470X24000685"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2024.100885","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement and complement regulatory protein in allogeneic and xenogeneic kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2024.100885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100885"}}